<DOC>
	<DOCNO>NCT01366352</DOCNO>
	<brief_summary>This single-center , double-blind , randomize , cross-over Phase 1 study normal , healthy volunteer . Study treatment entail single dos two different formulation MNTX tablet .</brief_summary>
	<brief_title>Pharmacokinetics Bioavailability Comparison Two Different Formulations MNTX Tablets</brief_title>
	<detailed_description />
	<mesh_term>Methylnaltrexone</mesh_term>
	<criteria>1 . Weight 55 85 kg 2 . In good health , base history , physical examination , appropriate laboratory diagnostic test screen , evidence clinically significant chronic medical condition 3 . Nonsmokers . 1 . History evidence cardiovascular , gastrointestinal , hepatic , musculoskeletal , neurological , pulmonary , renal , significant chronic illness 2 . History asthma , allergic skin rash , significant allergy , immunologic disorder 3 . Consumption barbiturates inducer inhibitor CYP450 4 . History suspicion alcohol drug abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>